Clinical Trial Update: Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating topotecan with erlotinib in topotecan-pretreated ovarian cancer was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Topotecan (topotecan)

Snippet

Sponsor: NYU Langone Health | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-01-16